AMENDMENT TO PLAN. Immediately following the Closing, the Company shall amend the Plan to increase the number of shares authorized for issuance under the Plan by an amount determined by the Company’s Compensation Committee of the Board of Directors.
Appears in 2 contracts
Sources: Series E Preferred Stock and Warrant Purchase Agreement (Roka BioScience, Inc.), Series E Preferred Stock and Warrant Purchase Agreement (Roka BioScience, Inc.)